Literature DB >> 12110515

Water permeability of aquaporin-4 is decreased by protein kinase C and dopamine.

Marina Zelenina1, Sergey Zelenin, Alexander A Bondar, Hjalmar Brismar, Anita Aperia.   

Abstract

Aquaporin-4 (AQP4) plays an important role in the basolateral movement of water in the collecting duct. Here we show that this water channel can be dynamically regulated. Water permeability (P(f)) was measured in individual LLC-PK1 cells that were transiently transfected with AQP4. To identify which cells were transfected, AQP4 was tagged at the NH2 terminus with green fluorescent protein. Transfected cells showed a strong fluorescent signal in basolateral membrane and a low-to-negligible signal in the cytosol and apical membrane. Activation of protein kinase C (PKC) with phorbol 12,13-dibutyrate (PDBu) significantly decreased P(f) of cells expressing AQP4 but had no effect on neighboring untransfected cells. No redistribution of AQP4 in response to PDBu was detected. Dopamine also decreased the P(f) in transfected cells. The effect was abolished by the PKC inhibitor Ro 31-8220. Reduction of AQP4 water permeability by PDBu and dopamine was abolished by point mutation of Ser(180), a consensus site for PKC phosphorylation. We conclude that PKC and dopamine decrease AQP4 water permeability via phosphorylation at Ser180 and that the effect is likely mediated by gating of the channel.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110515     DOI: 10.1152/ajprenal.00260.2001

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  55 in total

1.  Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury.

Authors:  Shilin Yang; Bing Yao; Yunfeng Zhou; Huiyong Yin; Ming-Zhi Zhang; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-14

Review 2.  Molecular biology of water and salt regulation in the kidney.

Authors:  C Esteva-Font; J Ballarin; P Fernández-Llama
Journal:  Cell Mol Life Sci       Date:  2011-10-14       Impact factor: 9.261

3.  Phosphorylation of aquaporin-2 regulates its water permeability.

Authors:  Kayoko Eto; Yumi Noda; Saburo Horikawa; Shinichi Uchida; Sei Sasaki
Journal:  J Biol Chem       Date:  2010-10-22       Impact factor: 5.157

Review 4.  Aquaporins in kidney pathophysiology.

Authors:  Yumi Noda; Eisei Sohara; Eriko Ohta; Sei Sasaki
Journal:  Nat Rev Nephrol       Date:  2010-01-26       Impact factor: 28.314

Review 5.  Invertebrate aquaporins: a review.

Authors:  Ewan M Campbell; Andrew Ball; Stefan Hoppler; Alan S Bowman
Journal:  J Comp Physiol B       Date:  2008-07-02       Impact factor: 2.200

6.  Acute and chronic changes in aquaporin 4 expression after spinal cord injury.

Authors:  O Nesic; J Lee; Z Ye; G C Unabia; D Rafati; C E Hulsebosch; J R Perez-Polo
Journal:  Neuroscience       Date:  2006-10-30       Impact factor: 3.590

7.  Differential water permeability and regulation of three aquaporin 4 isoforms.

Authors:  Robert A Fenton; Hanne B Moeller; Marina Zelenina; Marteinn T Snaebjornsson; Torgeir Holen; Nanna MacAulay
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

8.  Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway.

Authors:  Bing Yao; Raymond C Harris; Ming-Zhi Zhang
Journal:  Hypertension       Date:  2009-09-21       Impact factor: 10.190

9.  Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.

Authors:  Christina R Marmarou; Xiuyin Liang; Naqeeb H Abidi; Shanaz Parveen; Keisuke Taya; Scott C Henderson; Harold F Young; Aristotelis S Filippidis; Clive M Baumgarten
Journal:  Brain Res       Date:  2014-06-13       Impact factor: 3.252

Review 10.  Fluid transport phenomena in ocular epithelia.

Authors:  Oscar A Candia; Lawrence J Alvarez
Journal:  Prog Retin Eye Res       Date:  2008-01-15       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.